Focus Point Holdings Bhd (XKLS:0157) ROE %: 23.80% (As of Mar. 2026) — 32% Above Median


XKLS:0157 Focus Point Holdings Bhd XKLS:0157
70 GF Score
Price RM0.51
GF Value RM0.67
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Focus Point Holdings Bhd ROE %?

Focus Point Holdings Bhd XKLS:0157 70 ROE % is 23.80% as of Mar. 2026, which is 32% above its 10-year median of 18.04. GuruFocus rates XKLS:0157 with a GF Score™ of 70/100 and a GF Value™ of RM0.67 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Focus Point Holdings Bhd ranks better than 94.48% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Focus Point Holdings Bhd's annualized net income for the quarter that ended in Mar. 2026 was RM36.8 Mil. Focus Point Holdings Bhd's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was RM154.6 Mil. Therefore, Focus Point Holdings Bhd's annualized ROE % for the quarter that ended in Mar. 2026 was 23.80%.

The historical rank and industry rank for Focus Point Holdings Bhd's ROE % or its related term are showing as below:

XKLS:0157' s ROE % Range Over the Past 10 Years
Min: -2.24   Med: 18.04   Max: 40.41
Current: 24.38

During the past 13 years, Focus Point Holdings Bhd's highest ROE % was 40.41%. The lowest was -2.24%. And the median was 18.04%.

XKLS:0157's ROE % is ranked better than
94.48% of 797 companies
in the Medical Devices & Instruments industry
Industry Median: 2.4 vs XKLS:0157: 24.38

Focus Point Holdings Bhd  (XKLS:0157) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=36.792/154.6175
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(36.792 / 309.08)*(309.08 / 339.6085)*(339.6085 / 154.6175)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.9 %*0.9101*2.1964
=ROA %*Equity Multiplier
=10.83 %*2.1964
=23.80 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=36.792/154.6175
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (36.792 / 49.448) * (49.448 / 54.844) * (54.844 / 309.08) * (309.08 / 339.6085) * (339.6085 / 154.6175)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7441 * 0.9016 * 17.74 % * 0.9101 * 2.1964
=23.80 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Focus Point Holdings Bhd ROE % Related Terms


Focus Point Holdings Bhd ROE % Historical Data

* Premium members only.

The historical data trend for Focus Point Holdings Bhd's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Focus Point Holdings Bhd ROE % Chart

Focus Point Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.50 40.41 27.45 26.23 24.37

Focus Point Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.75 23.62 17.23 32.77 23.80

XKLS:0157 vs ISRG, BDX, MDLN: ROE % Comparison

For the Medical Instruments & Supplies subindustry, Focus Point Holdings Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Focus Point Holdings Bhd ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Focus Point Holdings Bhd's ROE % distribution charts can be found below:

* The bar in red indicates where Focus Point Holdings Bhd's ROE % falls into.


XKLS:0157
70GF Score
Focus Point Holdings Bhd XKLS:0157
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Focus Point Holdings Bhd ROE % Calculation

Focus Point Holdings Bhd's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=35.028/( (135.018+152.458)/ 2 )
=35.028/143.738
=24.37 %

Focus Point Holdings Bhd's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=36.792/( (152.458+156.777)/ 2 )
=36.792/154.6175
=23.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 23.80% mean?
Focus Point Holdings Bhd (XKLS:0157) has a ROE % of 23.80% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Focus Point Holdings Bhd and its competitors. This is 32% above median its historical median of 18.04. According to the industry distribution chart, Focus Point Holdings Bhd ranks #44 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 5.5%.
Is Focus Point Holdings Bhd's ROE % too high?
Focus Point Holdings Bhd's current ROE % of 23.80% is 32% above median its 10-year median of 18.04. The Medical Devices & Instruments industry median ROE % is 2.40. Focus Point Holdings Bhd's value of 23.80% is 891.7% above this industry median. Based on the distribution chart, Focus Point Holdings Bhd ranks #44 out of 797 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Focus Point Holdings Bhd has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Focus Point Holdings Bhd's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Focus Point Holdings Bhd ranks #44 out of 797 companies for ROE %. This places Focus Point Holdings Bhd in the top 6% of its industry — outperforming the majority of peers. The industry median ROE % is 2.40. Focus Point Holdings Bhd's value of 23.80% is 891.7% above this benchmark. While the company's 10-year median is 18.04 vs. the industry median of 2.40, Focus Point Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Focus Point Holdings Bhd's current ROE % of 23.80% is 891.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Focus Point Holdings Bhd and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Focus Point Holdings Bhd's current ROE % is 23.80%, which is 32% above median its own 10-year median of 18.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Focus Point Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Focus Point Holdings Bhd (XKLS:0157) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.67, compared to a current price of RM0.51 — trading 23.9% below its estimated fair value. The current ROE % is 23.80%, which is 32% above median its 10-year median of 18.04 and 891.7% above the Medical Devices & Instruments industry median of 2.40. Focus Point Holdings Bhd's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Focus Point Holdings Bhd (XKLS:0157), the current ROE % is 23.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Focus Point Holdings Bhd (XKLS:0157) Overvalued in 2026?

Based on GuruFocus' analysis, Focus Point Holdings Bhd stock appears to be undervalued. The current stock price of RM0.51 is trading 23.9% below its estimated GF Value™ of RM0.67. GuruFocus considers Focus Point Holdings Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0157:

  • ROE %: 23.80% (32% above median its 10-year median of 18.04)
  • GF Value™: RM0.67 vs. price of RM0.51 (23.9% below fair value)
  • GF Score™: 70/100 with 2 warning signs
  • Industry Position: 891.7% above the Medical Devices & Instruments median (#44 of 797)

No single metric tells the full story. See the XKLS:0157 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Focus Point Holdings Bhd Business Description

Address Jalan PJU 1/37, Unit 1, 3, 5 and 7, Dataran Prima, Petaling Jaya, SGR, MYS, 47301
Focus Point Holdings Bhd operates professional eye care centres, trading of eyewear and eye care products, investment holding, retail sale of other food products, management of franchised professional eye care centres, provision of medical eye care services, and operation of food and beverages business. The company's operating segments are the Optical segment and the Food and Beverages segment. The firm generates the majority of its revenue from the Optical segment, which is engaged in the retailing of optical and related products, including the management of franchised optical outlets. The food and beverages segment is into the provision of food and beverage services, including the management of franchised food and beverage outlets.
70GF Score

Get the complete analysis for XKLS:0157

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.51
Price
RM0.67
GF Value